Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Romo

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Journal of Neurosurgery. Case Lessons|March 23, 2026
Malignant peripheral nerve sheath tumors arising in SMARCB1-associated schwannomatosis: illustrative casesTaha Khalilullah, Xinlan Yang, Jonathan Yao, et al.
Neurology. Education|June 13, 2025
Curriculum Innovation: The Osler Apprenticeship in Neurology: Building a Sustainable Pathway for Learners Interested in Medical EducationRebecca E Khamishon, Grant Wilson, Julie Yi, et al.
Neuro-Oncology|February 25, 2023
Clinical, histological, and molecular features of gliomas in adults with neurofibromatosis type 1Carlos G Romo, Anna F Piotrowski, Jian L Campian, et al.
The Journal of Investigative Dermatology|May 6, 2023
cNF-Skindex in Adults Living with Neurofibromatosis 1: Severity Strata in France and Validation in United States AdultsLaura Fertitta, Kavita Y Sarin, Christina Bergqvist, et al.
The Journal of Investigative Dermatology|June 18, 2023
Existing and Developing Preclinical Models for Neurofibromatosis Type 1-Related Cutaneous NeurofibromasVerena Staedtke, Piotr Topilko, Lu Q Le, et al.
The Journal of Investigative Dermatology|June 18, 2023
Current and Emerging Imaging Techniques for Neurofibromatosis Type 1-Associated Cutaneous NeurofibromasYingjoy Li, Jaishri O Blakeley, Ina Ly, et al.
Neuro-Oncology Advances|July 10, 2020
NCI-CONNECT: Comprehensive Oncology Network Evaluating Rare CNS Tumors-Histone Mutated Midline Glioma Workshop ProceedingsBrett J Theeler, Yamini Dalal, Michelle Monje, et al.
Neuro-Oncology|June 8, 2020
Baseline requirements for novel agents being considered for phase II/III brain cancer efficacy trials: conclusions from the Adult Brain Tumor Consortium's first workshop on CNS drug deliveryStuart A Grossman, Carlos G Romo, Michelle A Rudek, et al.
Neuro-Oncology Advances|October 2, 2020
Proceedings of the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) Adult Medulloblastoma WorkshopMarta Penas-Prado, Brett J Theeler, Brittany Cordeiro, et al.
Journal of the American Academy of Dermatology|October 8, 2025
Measurement of the severity related to cutaneous neurofibromas in neurofibromatosis type 1: Development and validation of the Nef-ASILaura Fertitta, Arnaud Jannic, Christina Bergqvist, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Journal of Neurosurgery. Case Lessons|March 23, 2026
Malignant peripheral nerve sheath tumors arising in SMARCB1-associated schwannomatosis: illustrative casesTaha Khalilullah, Xinlan Yang, Jonathan Yao, et al.
Neurology. Education|June 13, 2025
Curriculum Innovation: The Osler Apprenticeship in Neurology: Building a Sustainable Pathway for Learners Interested in Medical EducationRebecca E Khamishon, Grant Wilson, Julie Yi, et al.
Neuro-Oncology|February 25, 2023
Clinical, histological, and molecular features of gliomas in adults with neurofibromatosis type 1Carlos G Romo, Anna F Piotrowski, Jian L Campian, et al.
The Journal of Investigative Dermatology|May 6, 2023
cNF-Skindex in Adults Living with Neurofibromatosis 1: Severity Strata in France and Validation in United States AdultsLaura Fertitta, Kavita Y Sarin, Christina Bergqvist, et al.
The Journal of Investigative Dermatology|June 18, 2023
Existing and Developing Preclinical Models for Neurofibromatosis Type 1-Related Cutaneous NeurofibromasVerena Staedtke, Piotr Topilko, Lu Q Le, et al.
The Journal of Investigative Dermatology|June 18, 2023
Current and Emerging Imaging Techniques for Neurofibromatosis Type 1-Associated Cutaneous NeurofibromasYingjoy Li, Jaishri O Blakeley, Ina Ly, et al.
Neuro-Oncology Advances|July 10, 2020
NCI-CONNECT: Comprehensive Oncology Network Evaluating Rare CNS Tumors-Histone Mutated Midline Glioma Workshop ProceedingsBrett J Theeler, Yamini Dalal, Michelle Monje, et al.
Neuro-Oncology|June 8, 2020
Baseline requirements for novel agents being considered for phase II/III brain cancer efficacy trials: conclusions from the Adult Brain Tumor Consortium's first workshop on CNS drug deliveryStuart A Grossman, Carlos G Romo, Michelle A Rudek, et al.
Neuro-Oncology Advances|October 2, 2020
Proceedings of the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) Adult Medulloblastoma WorkshopMarta Penas-Prado, Brett J Theeler, Brittany Cordeiro, et al.
Journal of the American Academy of Dermatology|October 8, 2025
Measurement of the severity related to cutaneous neurofibromas in neurofibromatosis type 1: Development and validation of the Nef-ASILaura Fertitta, Arnaud Jannic, Christina Bergqvist, et al.
Pageof 7